NEO-N BCT 1902
22 Dec 2020
NEO-N BCT
ACTRN12619001308189
A randomised phase II trial evaluating the efficacy of a nivolumab monotherapy lead in “window” or commencement of nivolumab concurrently with paclitaxel and carboplatin as neoadjuvant therapy in early stage triple negative breast cancer
Breast Cancer Trials
Cancer Type | Breast |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | Triple Negative Breast Cancer |
Cancer Stage | Early\In Situ, Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2020-03-01 |
Anticipated End Date | 2022-07-31 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Hannah Adelson |
Hannah.adelson@sa.gov.au | |
Phone | 08 8206 4835 |
Principal Investigator | Professor Chris Karapetis |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs